Admitted patients with a cerebrovascular accident (stroke) or transient ischaemic attack (TIA) who received pharmacist intervention in the stroke prevention clinic (SPC) are less likely to be readmitted and more likely to show improvement in surrogate markers, such as blood pressure (BP) and haemoglobin (Hb)A1c, a study has shown.
Using thiopurines in combination with scheduled adalimumab monotherapy for longer than 6 months in the maintenance treatment of patients with Crohn’s disease (CD) does not appear to yield additional beneficial effect, according to data from the DIAMOND2 trial.
A dermatology outpatient setting in Singapore has seen a moderately high prevalence of steroid phobia, with gender differences for topical corticosteroids (TCS) phobia, according to a study. Misconceptions also exist regarding the side effects of steroids.
The addition of the dual SGLT*1 and SGLT2 inhibitor sotagliflozin to insulin led to improvements in glycaemic control, body weight, and systolic blood pressure (SBP) in overweight/obese individuals with type 1 diabetes (T1D), according to a post hoc analysis presented at EASD 2019.
Surgery may be a potential treatment for patients who have persistent heartburn due to gastroesophageal reflux disease (GERD) despite treatment with proton-pump inhibitors (PPIs), according to a recent study.
An experimental strategy of 1-month dual antiplatelet therapy (DAPT) followed by long-term ticagrelor monotherapy (23 months) shows a favourable balance of ischaemia and bleeding risks in patients who undergo multivessel percutaneous coronary intervention (PCI), according to a recent study.
Providing free blood glucometers and related supplies for self-monitoring of blood glucose (SMBG) effectively improves self-care among patients with uncontrolled type 2 diabetes (T2D), according to a Singapore study.
Daily use of the selective oral Bruton’s tyrosine kinase inhibitor evobrutinib in the treatment of patients with relapsing multiple sclerosis helps reduce the number of gadolinium-enhancing lesions, according to the results of a phase II trial.
Long-term treatment with glucocorticoids (GC) is necessary in polymyalgia rheumatica (PMR), but preliminary data of a study suggests that use of amino bisphosphonates (N-BP) correlates with GC discontinuation in the management of PMR.
The combination of emtricitabine and dolutegravir with either a tenofovir alafenamide fumarate (TAF) or tenofovir disoproxil fumarate (TDF)-based regimen fared similarly to a TDF-emtricitabine-efavirenz regimen in reducing HIV-1 RNA levels, according to results of the phase III ADVANCE* study presented at IAS 2019.